Century Therapeutics (NASDAQ: IPSC) is a biotechnology company advancing a pipeline of induced pluripotent stem cell (iPSC)-derived cell therapies with the potential to meaningfully address autoimmune diseases, including type 1 diabetes, and cancer. The company’s therapies are derived from its iPSC cell foundry and leverage its novel immune evasion engineering technology, Allo-Evasion™. Century believes its approach to developing off-the-shelf cell therapies will expand patient access and provide advantages over existing cell therapies which will ultimately advance the course of care. Role: Century Therapeutics is seeking a highly motivated Senior Research Associate to join our Beta Islet Differentiation team. In this role, you will contribute to the development of our T1D CNTY-813 cell therapy by executing and optimizing differentiation of induced pluripotent stem cells (iPSCs) into functional beta islets. You will play a key role in refining differentiation protocols and driving analytical characterization of cell populations, with a strong emphasis on flow cytometry, qPCR, and ELISA-based readouts. This position is ideal for someone with hands-on experience in stem cell biology who enjoys experimental optimization, data generation, and assay execution in a fast-paced environment.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level